Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days

PURPOSE: Co-administration of the 5α-reductase inhibitor dutasteride increases the oral testosterone bioavailability in men with experimentally induced hypogonadism. We examined oral testosterone with and without dutasteride administration in hypogonadal men for 28 days. MATERIALS AND METHODS: We ra...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Urol
Prif Awduron: Amory, John K., Bush, Mark A., Zhi, Hui, Caricofe, Ralph B., Matsumoto, Alvin M., Swerdloff, Ronald S., Wang, Christina, Clark, Richard V.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267472/
https://ncbi.nlm.nih.gov/pubmed/21168874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.09.089
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg